Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An International Multicenter Cohort Study on Surgical and Oncological Outcome.
Article in Annals of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
37 authors.
Thomas F StoopAmsterdam UMC, location University of Amsterdam, Department of Surgery,Amsterdam, The Netherlands.ORCID 0000-0003-3328-4516
Adrienne MolnárDepartment of Surgery, Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO.ORCID 0000-0002-3088-915
Leonard W F SeelenDepartment of Surgery, Regional Academic Cancer Center Utrecht, University Medical Center Utrecht/St. Antonius Hospital Nieuwegein, Utrecht & Nieuwegein, The Netherlands.ORCID 0000-0002-2712-8026
Toshitaka SugawaraDepartment of Surgery, Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO.ORCID 0000-0001-7211-6094
Jacobien C M ScheepensDepartment of Surgery, Regional Academic Cancer Center Utrecht, University Medical Center Utrecht/St. Antonius Hospital Nieuwegein, Utrecht & Nieuwegein, The Netherlands.
Ammar A JavedAmsterdam UMC, location University of Amsterdam, Department of Surgery,Amsterdam, The Netherlands.ORCID 0000-0002-5463-5250
Asif HalimiDepartment of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden.ORCID 0000-0002-0343-8978
Atsushi ObaDepartment of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan.ORCID 0000-0002-7315-0830
Bas Groot KoerkampDepartment of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0000-0003-1917-6973
Bodil AnderssonDepartment of Clinical Sciences Lund, Surgery, Lund University and Skåne University Hospital, Lund, Sweden.ORCID 0000-0001-5591-0659
Caroline WilliamssonDepartment of Clinical Sciences Lund, Surgery, Lund University and Skåne University Hospital, Lund, Sweden.ORCID 0000-0002-9743-3149
Christopher L WolfgangDepartment of Surgery, Division of Surgical Oncology, New York University Medical Center, New York City, NY.ORCID 0000-0002-8717-0373
Daisuke BanDepartment of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine, Institute of Science Tokyo, Tokyo, Japan.ORCID 0000-0003-0868-8519
Ernesto SparrelidDepartment of Clinical Science, Intervention and Technology, Division of Surgery, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0003-0259-8328
Hjalmar C van SantvoortDepartment of Surgery, Regional Academic Cancer Center Utrecht, University Medical Center Utrecht/St. Antonius Hospital Nieuwegein, Utrecht & Nieuwegein, The Netherlands.ORCID 0009-0007-1218-2883
Ingmar F RompenAmsterdam UMC, location University of Amsterdam, Department of Surgery,Amsterdam, The Netherlands.ORCID 0000-0002-0257-1654
I Quintus MolenaarDepartment of Surgery, Regional Academic Cancer Center Utrecht, University Medical Center Utrecht/St. Antonius Hospital Nieuwegein, Utrecht & Nieuwegein, The Netherlands.
Joseph R HabibDepartment of Surgery, Division of Surgical Oncology, New York University Medical Center, New York City, NY.ORCID 0000-0003-3445-2278
Lysanne P M BeukDepartment of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0009-0007-7887-6730
Niek J GeerdinkAmsterdam UMC, location University of Amsterdam, Department of Surgery,Amsterdam, The Netherlands.ORCID 0000-0001-9876-863
Roeland F de WildeDepartment of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID 0009-0003-0444-8697
Olivier R BuschAmsterdam UMC, location University of Amsterdam, Department of Surgery,Amsterdam, The Netherlands.ORCID 0000-0001-9605-6831
Oskar SwartlingDepartment of Clinical Science, Intervention and Technology, Division of Surgery, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0002-3783-1567
Paulina Bereza-CarlsonDepartment of Clinical Sciences Lund, Surgery, Lund University and Skåne University Hospital, Lund, Sweden.
Poya GhorbaniDepartment of Clinical Science, Intervention and Technology, Division of Surgery, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden.ORCID 0000-0003-2102-7168
Reeve L KruizeAmsterdam UMC, location University of Amsterdam, Department of Surgery,Amsterdam, The Netherlands.
Richard D SchulickDepartment of Surgery, Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO.ORCID 0000-0001-7360-7338
Salvador Rodriguez FrancoDepartment of Surgery, Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO.ORCID 0000-0001-9786-3651
Tatsunori MiyataDivision of Hepato-biliary-pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.ORCID 0000-0003-4749-4741
Oskar FranklinDepartment of Surgery, Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO.ORCID 0000-0002-3777-6887
Yosuke InoueDivision of Hepato-biliary-pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.ORCID 0000-0001-5812-6608
Marc G BesselinkAmsterdam UMC, location University of Amsterdam, Department of Surgery,Amsterdam, The Netherlands.ORCID 0000-0003-2650-9350
Marco Del ChiaroDepartment of Surgery, Division of Surgical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO.
International Collaborative Group on Locally Advanced Pancreatic Cancer
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
objectiveTo investigate whether tangential versus segmental portomesenteric venous resection (PVR) impacts surgical and oncological outcomes in patients undergoing pancreatoduodenectomy for pancreatic cancer with portomesenteric vein (PMV) involvement.
backgroundCurrent comparative studies on tangential versus segmental PVR as part of pancreatoduodenectomy for pancreatic cancer include all degrees of PMV involvement, including cases where tangential PVR may not be a feasible approach, limiting the clinical applicability.
methodsAn international retrospective study in 10 centers from 5 countries, including all consecutive patients after pancreatoduodenectomy with PVR for pancreatic cancer with ≤180 degrees PMV involvement on cross-sectional imaging at diagnosis (2014-2020). Cox and logistic regression analyses were performed to investigate the association of tangential versus segmental PVR with overall survival (OS) from surgery, recurrence-free survival (RFS), locoregional recurrence, and in-hospital/30-day major morbidity, adjusting for potential confounders.
resultsOverall, 357 patients who underwent pancreatoduodenectomy with PVR were included (42% tangential PVR, 58% segmental PVR). The adjusted risk for in-hospital/30-day major morbidity was 23% (95% CI, 17-32) after tangential and 23% (95% CI, 17-30) after segmental PVR ( P =0.98). After adjusting for confounders, PVR type was not associated with OS [HR=0.94 (95% CI, 0.69-1.30)], RFS [HR=0.94 (95% CI, 0.69-1.28)], and locoregional recurrence [OR=0.76 (95% CI, 0.40-1.46)].
conclusionsIn patients undergoing pancreatoduodenectomy for pancreatic cancer with ≤180 degrees PMV involvement, the type of PVR (ie, tangential vs segmental) was not associated with differences in surgical and oncological outcome. This suggests that if both procedures are technically feasible, surgeons can choose the type of PVR based on their preference.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Tangential Versus Segmental Portomesenteric Venous Resection During Pancreatoduodenectomy for Pancreatic Cancer: An International Multicenter Cohort Study on Surgical and Oncological Outcome. · full record | OpenQuestion